AstraZeneca PLC (AZN) — Long-term Investment Intensity
AstraZeneca PLC (AZN) has a Long-term Investment Intensity of 2.5% as of December 2019. Long-term investments of GBX1.51 Billion represent 2.5% of total assets of GBX61.38 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check AZN cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
AstraZeneca PLC Long-term Investment Intensity (2014–2019)
This chart shows how AstraZeneca PLC's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 2.5%, reflecting long-term investments of GBX1.51 Billion against total assets of GBX61.38 Billion GBX. Explore AZN cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for AstraZeneca PLC (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for AstraZeneca PLC from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is AstraZeneca PLC worth.
| Year | LT Investment Intensity | LT Investments (GBX) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 2.5% | GBX1.51 Billion | GBX61.38 Billion | ▲ +0.9 pp |
| 2018 | 1.6% | GBX978.00 Million | GBX60.65 Billion | ▼ -0.2 pp |
| 2017 | 1.8% | GBX1.12 Billion | GBX63.35 Billion | ▲ +0.3 pp |
| 2016 | 1.4% | GBX891.00 Million | GBX62.53 Billion | ▲ +0.3 pp |
| 2015 | 1.1% | GBX669.00 Million | GBX60.06 Billion | ▼ -0.1 pp |
| 2014 | 1.2% | GBX722.00 Million | GBX58.59 Billion | — |